Piper Sandler Research Analysts Reduce Earnings Estimates for Paragon 28 Inc (NYSE:FNA)

Paragon 28 Inc (NYSE:FNA) – Equities researchers at Piper Sandler cut their FY2021 EPS estimates for Paragon 28 in a report released on Monday, November 22nd. Piper Sandler analyst M. O’brien now anticipates that the company will post earnings of ($0.22) per share for the year, down from their prior estimate of ($0.17). Piper Sandler currently has a “Overweight” rating and a $30.00 target price on the stock. Piper Sandler also issued estimates for Paragon 28’s FY2022 earnings at ($0.19) EPS.

Paragon 28 (NYSE:FNA) last announced its earnings results on Sunday, November 21st. The company reported ($0.12) EPS for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.04).

A number of other brokerages have also weighed in on FNA. JMP Securities reaffirmed a “buy” rating and set a $29.00 price objective on shares of Paragon 28 in a report on Tuesday. Canaccord Genuity started coverage on Paragon 28 in a research report on Tuesday, November 9th. They set a “buy” rating and a $28.00 target price on the stock. Finally, Needham & Company LLC started coverage on Paragon 28 in a research report on Tuesday, November 9th. They set a “buy” rating and a $31.00 target price on the stock.

FNA stock opened at $21.16 on Thursday. Paragon 28 has a 1 year low of $17.25 and a 1 year high of $25.41.

About Paragon 28

Paragon 28 Inc is a medical device company exclusively focused on the foot and ankle orthopedic market. Paragon 28 Inc is based in ENGLEWOOD, Colo.

Featured Story: Understanding and Trading Breakout Stocks

Earnings History and Estimates for Paragon 28 (NYSE:FNA)

Receive News & Ratings for Paragon 28 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paragon 28 and related companies with MarketBeat.com's FREE daily email newsletter.